Chief Medical Officer (6) · Arcturus Therapeutics Holdings Inc. (ARCT)

Steven Hughes

A named executive officer of Arcturus Therapeutics in every fiscal year CompBrief holds from FY2019 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$4,876,625

Salary $415,000Stock awards $0Bonus $249,000

FY2019: $299,873

5th of 5 named executive officers at Arcturus Therapeutics by FY2020 total.

5 named officers on file for Arcturus Therapeutics, FY2020

Steven Hughes’s pay file — $29

  • 2 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing
  • ARCT’s disclosed peer group of 15 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Arcturus Therapeutics’s whole pay program stands against its peers

  • Arcturus Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ARCT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 30, 2021 (DEF 14A).

Free

Get Steven Hughes’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Steven Hughes compensation by year

Arcturus Therapeutics Summary Compensation Table · all 2 fiscal years held
In US dollars, as Arcturus Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2019FY2020
Salary$299,873$415,000
Bonus$0$249,000
Stock awards$0$0
Option awards$0$4,212,625
Non-equity incentive$0$0
Pension and deferred compensation$0$0
All other$0$0
Total$299,873$4,876,625

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Arcturus Therapeutics Holdings Inc. DEF 14A filed April 30, 2021, accession 0001193805-21-000583, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Arcturus Therapeutics Holdings Inc. filed document, accession 0001193805-21-000583. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2021.

$300K
$4.9M
FY19
FY20
SalaryBonusOption awards

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
Option75,000—$14.12
Option12,500—$48.84
Option50,000—$99.29

Per the Outstanding Equity Awards at Fiscal Year-End table in Arcturus Therapeutics Holdings Inc.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

Arcturus Therapeutics’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Joseph PaynePresident and Chief Executive Officer, Director$12,861,500
Andy SassineChief Financial Officer (5)$7,654,800
Padmanabh ChivukulaChief Scientific Officer, Chief Operating Officer$7,472,600
Lance KurataChief Legal Officer$5,140,550
Steven Hughes · this pageChief Medical Officer (6)$4,876,625

The full Arcturus Therapeutics compensation record

free company brief

This page is one person within Arcturus Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Arcturus Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Steven Hughes's compensation dossier · One-time report. No refunds.